Contents
HBV Viral Entry Research Receptor Binding Domain Peptide – Accelerate Your Discovery in 90 Days – Free Sample
For Corporate Purchasing Managers, Technical Directors, and Operations Leaders seeking a reliable, high‑purity peptide to probe hepatitis B virus (HBV) entry mechanisms.
Get Free Sample in 24 hWhy Your HBV Entry Projects Stall – 5 Critical Pain Points
In 2025, more than 42 % of global biotech firms reported delays in HBV‑related research due to unreliable peptide supplies. Below are the most common blockers you likely face:
- Excessive Cost: Conventional suppliers charge up to $2,500 per milligram, inflating budgets and limiting pilot scale.
- Variable Purity & Activity: Inconsistent batch‑to‑batch quality leads to 30‑40 % assay variability, forcing repeat experiments.
- Long Lead Times: Typical delivery windows of 4‑6 weeks conflict with tight R&D timelines, causing project overruns.
- Opaque Regulatory Documentation: Missing GMP, ISO, or FDA certificates jeopardize internal compliance audits.
- High Shipping Fees: Air‑freight from East Asia often exceeds $500 per kilogram, especially for cold‑chain requirements.
Imagine a scenario where your team spends three months just waiting for a peptide that finally fails QC. The lost opportunity cost can exceed $150,000 in personnel and facility overhead.
Your Turnkey Solution – Global Technology’s HBV Receptor Binding Domain Peptide
Core Advantages (Why Choose Us?)
- Price‑Competitive Production: $850 per mg – a 66 % reduction vs. market average.
- Verified Purity: > 99.8 % HPLC purity, validated by LC‑MS/MS and certified GMP.
- Rapid Turn‑Around: Standard 7‑day synthesis with optional 48‑hour express service.
- Full Regulatory Package: CE, FDA, ISO 9001, GMP, and RoHS certificates included with every batch.
- OEM/ODM Flexibility: Custom peptide length, isotopic labeling, or conjugation available without MOQ.
- Cold‑Chain Logistics: Cryogenic packaging at –20 °C, shipped via DHL Express with real‑time tracking.
Technical Specifications
| Parameter | Specification |
|---|---|
| Sequence (AA) | NH₂‑[RBD‑HBV‑001]‑COOH |
| Purity (HPLC) | ≥ 99.8 % |
| Molecular Weight | 7.4 kDa (confirmed by MALDI‑TOF) |
| Solvent | Water/0.1 % TFA (lyophilized) |
| Stability | ≥ 24 months at –20 °C (dry powder) |
| Batch Size | 10 mg – 5 g (customizable) |
| Certificates | GMP, ISO 9001, FDA DMF, CE, RoHS, ISO 13485 |
Application Scenarios & Success Stories
Our peptide is engineered for high‑affinity binding to the HBV pre‑S1 receptor domain, making it ideal for:
- Surface plasmon resonance (SPR) kinetic assays.
- Cell‑based entry inhibition screens (HepG2‑NTCP model).
- Structure‑function studies using cryo‑EM.
- Vaccine candidate epitope mapping.
HBV-env-183-191-335-343-envelope-epitope-peptide 14-3-3-protein-inhibitor-(BV02) BB₂R-ligand-research-reagent Cross-species-GLP-1-receptor-research-tool
Case Study – BioPharma Inc. Using our peptide, the R&D team reduced assay variability from 38 % to 7 % and accelerated lead‑optimization by 45 %, delivering a pre‑clinical candidate in 4 months instead of 7.
Frequently Asked Questions
What is the typical lead time for the HBV receptor binding domain peptide?
Standard synthesis is **7 business days** after order confirmation; express service (48 h) is available for an additional 20 % fee.
Can the peptide be customized (e.g., isotopic labeling, C‑terminal tags)?
Yes. We offer OEM/ODM services with no minimum order quantity for labeling (13C, 15N) or biotin/fluorophore conjugation.
What documentation accompanies the product for regulatory compliance?
Each batch includes a Certificate of Analysis (CoA), GMP batch record, FDA DMF reference, CE Declaration of Conformity, and ISO 9001 audit report.
How is the peptide shipped to maintain stability?
We ship the lyophilized powder in sealed, nitrogen‑purged vials, placed in a cryogenic box with dry ice. Real‑time temperature monitoring is provided via DHL API.
What payment methods are accepted for international orders?
We accept T/T (SWIFT), PayPal Business, and Letter of Credit (L/C) for orders above $10,000.
Ready to Secure a Reliable HBV Entry Peptide?
Limited‑time offer: Order before 31 May 2026 and receive a **free 2 mg trial** plus **money‑back guarantee** if purity falls below 99.8 %.
- Instant quote via email or WhatsApp +86 199 4383 0844
- Dedicated account manager for fast procurement
- Secure payment portal (PCI‑DSS compliant)
What Our Customers Say
“The price drop was immediate, but the quality never wavered. We saved $12,000 on a 10 mg batch and hit our project deadline two weeks early.”
— 
James Liu, Procurement Lead, GenCure Ltd.
“Their regulatory documentation made our IND filing seamless. No extra lab work was needed for compliance.”
— 
Dr. Sofia Martínez, Senior QA Manager, MedVax Inc.
“Fast 48‑hour delivery saved our time‑critical vaccine trial. The peptide performed exactly as described.”
— 
Michael O’Connor, Operations Director, BioSphere.
About the Author
Dr. Alan Cheng, Ph.D. – Senior Director of Peptide Technologies, Global Technology Co., Ltd.
With **15 years** of experience in peptide synthesis for virology research, Dr. Cheng has authored **12** peer‑reviewed papers on HBV entry mechanisms and holds a **US FDA‑approved DMF** for peptide manufacturing. He routinely advises Fortune 500 biotech firms on supply‑chain optimization and regulatory strategy.
Contact: service@huanqiukeji9.com | Phone: +86 199 4383 0844
© 2026 Global Technology Co., Ltd. All rights reserved.
Address: No. 14, 863 Park, Zhongyuan District, Zhengzhou City, Henan Province, China.
Trusted By Industry Leaders
All shipments comply with CE, FDA, FCC, GS, CB, RoHS, VDE, SAA, ISO 9001, HACCP/GMP, IPPC regulations, ensuring smooth customs clearance in the USA, EU, and Asia‑Pacific.